Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Seres Therapeutics
MCRB
$47.4M
| $632K | ﹤0.01% |
6,641
+910
| +16% | +$79.8K |
|
3252
ING
ING
$102B
| $631K | ﹤0.01% |
91,371
-11,421
| -11% | -$69.3K |
|
3253
WBI BullBear Quality 3000 ETF
WBIL
$31.2M
| $629K | ﹤0.01% |
24,114
-3,393
| -12% | -$87.4K |
|
3254
Hercules Capital
HTGC
$3.17B
| $628K | ﹤0.01% |
59,989
-3,378
| -5% | -$34.3K |
|
|
HTZ
3255
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $628K | ﹤0.01% |
444,665
-182,625
| -29% | -$580K |
|
|
MRNS
3256
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $627K | ﹤0.01% |
61,686
+2,209
| +4% | +$20.3K |
|
3257
MVB Financial
MVBF
$397M
| $625K | ﹤0.01% |
47,052
+4,638
| +11% | +$62.2K |
|
3258
iShares Agency Bond ETF
AGZ
$566M
| $622K | ﹤0.01% |
5,137
+2,949
| +135% | +$356K |
|
|
ORAN
3259
DELISTED
Orange
ORAN
| $620K | ﹤0.01% |
52,099
-4,117
| -7% | -$49K |
|
|
MYOV
3260
DELISTED
Myovant Sciences Ltd.
MYOV
| $619K | ﹤0.01% |
30,040
-1
| -0% | -$14 |
|
|
CMRX
3261
DELISTED
Chimerix, Inc.
CMRX
| $615K | ﹤0.01% |
198,400
+10,897
| +6% | +$28.2K |
|
|
MRLN
3262
DELISTED
Marlin Business Services Corp
MRLN
| $615K | ﹤0.01% |
72,726
-5,085
| -7% | -$39.4K |
|
|
YARW
3263
Yarrow Bioscience, Inc. Common Stock
YARW
$114M
| $614K | ﹤0.01% |
99
+50
| +102% | +$339K |
|
|
USX
3264
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $613K | ﹤0.01% |
102,286
-6,869
| -6% | -$31.4K |
|
|
GDEN
3265
DELISTED
Golden Entertainment
GDEN
| $611K | ﹤0.01% |
68,544
-8,069
| -11% | -$75.1K |
|
|
GRTS
3266
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $611K | ﹤0.01% |
91,897
+9,815
| +12% | +$66.1K |
|
3267
Princeton Bancorp
BPRN
$295M
| $609K | ﹤0.01% |
30,317
-448
| -1% | -$9.04K |
|
|
TAST
3268
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $609K | ﹤0.01% |
125,937
-19,633
| -13% | -$74.1K |
|
3269
CB Financial Services
CBFV
$192M
| $606K | ﹤0.01% |
27,798
+15,886
| +133% | +$355K |
|
3270
Clearfield
CLFD
$390M
| $606K | ﹤0.01% |
43,432
-179
| -0.4% | -$2.32K |
|
3271
iShares US Healthcare ETF
IYH
$3.77B
| $606K | ﹤0.01% |
14,075
+425
| +3% | +$17.9K |
|
3272
C&F Financial
CFFI
$288M
| $602K | ﹤0.01% |
18,097
-373
| -2% | -$12.8K |
|
|
NAGE
3273
Niagen Bioscience
NAGE
$242M
| $602K | ﹤0.01% |
131,159
-3,014
| -2% | -$13.5K |
|
3274
Ranpak Holdings
PACK
$464M
| $601K | ﹤0.01% |
+80,710
| New | +$593K |
|
|
BOCH
3275
DELISTED
Bank of Commerce Holdings (CA)
BOCH
| $601K | ﹤0.01% |
79,293
+3,097
| +4% | +$22.7K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.